首页> 外文期刊>Andrologia >Fertility after high-dose testosterone and intracytoplasmic sperm injection in a patient with androgen insensitivity syndrome with a previously unreported androgen receptor mutation
【24h】

Fertility after high-dose testosterone and intracytoplasmic sperm injection in a patient with androgen insensitivity syndrome with a previously unreported androgen receptor mutation

机译:高剂量睾丸激素和胞浆内精子注射后先前未报道的雄激素受体突变的雄激素不敏感综合征患者的生育能力

获取原文
获取原文并翻译 | 示例
           

摘要

We report on a case of a man with familial, X-linked, partial androgen insensitivity, in whom a new point mutation in the androgen receptor (AR) ligand-binding domain (causing a valine-to-alanine substitution at codon 686) was identified. High-dose prolonged testosterone therapy resulted in marked progression in patient's appearance and great improvement in sperm count and characteristics. In combination with intracytoplasmic microinjection, treatment resulted in fertility. This is believed to be the first report of such a case. This case supports high-dose testosterone therapeutic trial in this condition. Furthermore, it underscores the possibility of achieving fertility with current endocrine and assisted reproduction modalities, making some of these X-linked AR mutations paternally transmissible.
机译:我们报告了一例患有家族性,X连锁,部分雄激素不敏感的男人,其中一名新的雄激素受体(AR)配体结合域的点突变(导致在686位密码子被缬氨酸转为丙氨酸取代)确定。大剂量延长的睾丸激素治疗导致患者外表明显进展,精子数量和特征大大改善。结合胞浆内显微注射,治疗可导致生育。据信这是这种情况的第一份报告。该病例支持这种情况下的大剂量睾丸激素治疗试验。此外,它强调了利用当前的内分泌和辅助生殖方式实现生育的可能性,使其中一些X连锁的AR突变可以父系地传播。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号